Veterinary Drugs Compounding Market, by Drug Class (CNS Agents, Anti-infective Agents, Hormones and Substitutes, Anti-inflammatory Agents, and Others), by Animal Type (Companion Animals (Dogs, Cats, and Others), and Livestock Animals) by Formulation (Oral, Injectable, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
The compounding medications for animals is generally prepared by pharmacists or veterinarians. The Federal Food, Drug, and Cosmetic Act (FD&C Act) allows compounding of animal drugs when the active ingredient is derived from a finished FDA-approved drug rather than a bulk drug substance. A ‘bulk drug substance’ is a substance used in the manufacturing of a drug that becomes an active ingredient in the drug's finished dosage form.
Market Dynamics
Market players are focused on product launches or approvals, this could contribute to the growth of the global veterinary drugs compounding market over the forecast period. For instance, in April 2018, Golden Gate Veterinary Compounding Pharmacy, a company focused on producing high quality custom compounds for meeting the needs of both pets and pet owner announced launch of the Topi-Click Micro Pens. Topi-Click Micro transdermal pens are accurate than other transdermal pens and further eliminate user-variability. In addition to being easy to use and extremely accurate, Topi-Click indicates the measure of dose through each administration, so the person knows exactly how much product is used and how much amount is remaining.
Market players are focused on inorganic strategies such as partnerships and agreements with other market players. This is expected to drive the market growth over the forecast period. For instance, in March 2019, Wedgewood Pharmacy, one of the biggest compounding pharmacy in the U.S., entered into a partnership with Vetsource for adding prescribed compounded medications to Vetsource’s Home-Delivery catalog. Vetsource uses mobile-optimized ScriptRight ePrescribing tool for ordering over-the-counter and nutritional medication products.
Market players focused on initiatives and programs related to healthcare nutrition, which is expected to propel the growth of the global veterinary drugs compounding market. For instance, in June 2021, Covetrus, a veterinary medicine pharmacy, announced that it has acquired VCP, a platform in veterinary wellness plan administration that serves around 1,000 veterinary practices, with over 350,000 pets currently benefiting from VCP-enabled wellness plans. Covetrus will be using VCP's technology platform and infrastructure to provide new ways for veterinarians to foster stronger relationships with their pet parent clients and deliver better business and healthcare outcomes.
Key features of the study:
This report provides an in-depth analysis of global veterinary drugs compounding market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global veterinary drugs compounding market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Wedgewood Pharmacy, Pace Pharmacy, Tache Pharmacy, The Pet Apothecary, Pet Script, Golden Gate Veterinary Compounding Pharmacy, CareFirst Specialty Pharmacy, Triangle Compounding Pharmacy, Miller’s Pharmacy, and Davis Islands Pharmacy
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global veterinary drugs compounding market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global veterinary drugs compounding market
Detailed Segmentation:
Global Veterinary Drugs Compounding Market, By Drug Class:
CNS Agents
Anti-infective Agents
Hormones and Substitutes
Anti-inflammatory Agents
Others
Global Veterinary Drugs Compounding Market, By Animal Type:
Companion Animals
Dogs
Cats
Others
Livestock Animals
Global Veterinary Drugs Compounding Market, By Formulation:
Oral
Injectable
Others
Global Veterinary Drugs Compounding Market, By Region:
North America
By Drug Class:
CNS Agents
Anti-infective Agents
Hormones and Substitutes
Anti-inflammatory Agents
Others
By Animal Type:
Companion Animals
Dogs
Cats
Others
Livestock Animals
By Formulation:
Oral
Injectable
Others
By Country:
U.S.
Canada
Latin America
By Drug Class:
CNS Agents
Anti-infective Agents
Hormones and Substitutes
Anti-inflammatory Agents
Others
By Animal Type:
Companion Animals
Dogs
Cats
Others
Livestock Animals
By Formulation:
Oral
Injectable
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug Class:
CNS Agents
Anti-infective Agents
Hormones and Substitutes
Anti-inflammatory Agents
Others
By Animal Type:
Companion Animals
Dogs
Cats
Others
Livestock Animals
By Formulation:
Oral
Injectable
Others
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Drug Class:
CNS Agents
Anti-infective Agents
Hormones and Substitutes
Anti-inflammatory Agents
Others
By Animal Type:
Companion Animals
Dogs
Cats
Others
Livestock Animals
By Formulation:
Oral
Injectable
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Drug Class:
CNS Agents
Anti-infective Agents
Hormones and Substitutes
Anti-inflammatory Agents
Others
By Animal Type:
Companion Animals
Dogs
Cats
Others
Livestock Animals
By Formulation:
Oral
Injectable
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Drug Class:
CNS Agents
Anti-infective Agents
Hormones and Substitutes
Anti-inflammatory Agents
Others
By Animal Type:
Companion Animals
Dogs
Cats
Others
Livestock Animals
By Formulation:
Oral
Injectable
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Wedgewood Pharmacy*
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Pace Pharmacy
Tache Pharmacy
The Pet Apothecary
Pet Script
Golden Gate Veterinary Compounding Pharmacy
CareFirst Specialty Pharmacy
Triangle Compounding Pharmacy
Miller’s Pharmacy
Davis Islands Pharmacy.
“*” marked represents similar segmentation in other categories in the respective section.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook